I can jump in, if you like.
This is an important question. Let's keep in mind that the compromise text is a compromise in a way I consider to be very problematic. We're just focusing on article 31 of TRIPS and putting aside article 39, which is about non-IP or trade secrets. This is unfortunate, especially because, in the last 20 years, there has been an evolution in the organization of intellectual property and patents, where, more and more, the patent offers very little understanding of the technology itself and is way more focused on trade secrets.
The thing is, if you give away the recipe without the trade secrets that go along with it, when the trade secrets have become a central part of your capacity to produce the technology to vaccine, in the end, this compromise will not go very far.
What's important during times of pandemic? We're talking about COVID-19. We could have a new variant emerge that is very bad and the vaccine could stop working. Then we will be in the same movie again. We could have a different pandemic—ebola, for example.
We need to prepare for a capacity of sharing both the know-how and the technology. This is in article 39, which is excluded from the compromise. As well, we need to make sure that if there is help and technology transfer among countries, this will not bring a rainfall of lawsuits and litigation.